Raymond James Financial
DARE icon

Raymond James Financial’s Dare Bioscience DARE Stock Holding History

Raymond James Financial’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4K Sell
14,864
-470
-3% -$1.05K ﹤0.01% 5303
2026
Q1 		$27.9K Hold
15,334
– – ﹤0.01% 5185
2025
Q4 		$29.6K Hold
15,334
– – ﹤0.01% 5055
2025
Q3 		$32.2K Buy
15,334
+13,650
+811% +$30.8K ﹤0.01% 4869
2025
Q2 		$4.03K Buy
+1,684
New +$4.91K ﹤0.01% 6235

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Raymond James Financial's DARE Position: Q2 2026 in Review

Raymond James Financial reduced its Dare Bioscience (DARE) stake by 3.1% in Q2 2026, selling an estimated $1.05K and leaving 14,864 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5303.

Raymond James Financial first reported a position in DARE in Q2 2025 and has held it in 5 quarters since. The position peaked at $32.2K in Q3 2025. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Raymond James Financial held 14,864 shares of Dare Bioscience worth $31.4K as of Q2 2026.
  • Raymond James Financial sold 470 Dare Bioscience shares in Q2 2026, an estimated $1.05K.
  • Dare Bioscience made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5303 holding.
  • Raymond James Financial first reported a position in Dare Bioscience in Q2 2025 and has held it in 5 quarters since.
  • Raymond James Financial's Dare Bioscience position peaked at $32.2K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.